Kalaris Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold KLRS, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
10
Funds holding
$2258122
Total value held
Flat
4 added/new · 4 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Ubs Group Ag | $1066873 | 262131 | +262131 | NEW BUY |
| 2 | Raymond James Financial Inc | $395457 | 97164 | -21723 | -18.27% |
| 3 | Morgan Stanley | $294367 | 72326 | +33982 | +88.62% |
| 4 | Blackrock, Inc. | $221580 | 54442 | +18399 | +51.05% |
| 5 | State Street Corp | $107896 | 26510 | — | Held |
| 6 | Northern Trust Corp | $105165 | 25839 | +11390 | +78.83% |
| 7 | Goldman Sachs Group Inc | $65340 | 16054 | -94449 | -85.47% |
| 8 | Barclays Plc | $1233 | 303 | -4977 | -94.26% |
| 9 | Jpmorgan Chase & Co | $211 | 50 | — | Held |
| 10 | Royal Bank Of Canada | $0 | 12 | -91 | -88.35% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.